Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.14 billion.
Market Cap
1.11T
Revenue
110.14B
Profits
-39.62B
PE Ratio
n/a
Profit Margin
-35.97%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.02B | -0.53% | 73,209 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.50B | -2.84% | 93,405 | 14.34B |
| 3 | ARGX | argenx SE | 46.54B | -0.10% | 51,156 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.99B | -3.69% | 92,531 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.05B | -1.37% | 133,691 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 34.38B | 0.53% | 11,071 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 28.03B | 0.21% | 330,963 | 2.38B |
| 8 | BNTX | BioNTech SE | 21.21B | -1.17% | 33,025 | 3.37B |
| 9 | RVMD | Revolution Medicines, Inc. | 19.72B | 0.88% | 61,172 | - |
| 10 | ROIV | Roivant Sciences Ltd. | 19.70B | -1.15% | 687,213 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 19.45B | -1.96% | 455,946 | 1.94B |
| 12 | INCY | Incyte Corporation | 18.74B | -0.14% | 50,708 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.77B | -1.03% | 27,972 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.90B | 1.59% | 303,102 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.23B | -1.38% | 112,346 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.87B | -0.97% | 154,202 | 845.52M |
| 17 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.22B | 0.52% | 18,828 | 958.40M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.15B | -2.13% | 112,205 | 943.71M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.51B | -0.66% | 47,189 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.31B | -1.14% | 136,388 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.73B | -2.52% | 105,794 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.38B | 3.00% | 194,870 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.75B | -0.65% | 152,480 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.70B | -0.98% | 53,810 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.65B | -2.67% | 42,609 | 7.46M |
| 26 | CYTK | Cytokinetics, Incorporated | 8.33B | 1.55% | 217,401 | 88.04M |
| 27 | TECH | Bio-Techne Corporation | 8.33B | -0.49% | 115,289 | 1.22B |
| 28 | PCVX | Vaxcyte, Inc. | 8.23B | -2.21% | 73,408 | - |
| 29 | NUVL | Nuvalent, Inc. | 8.20B | -1.26% | 41,019 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.70B | -0.56% | 58,622 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.49B | -0.99% | 62,335 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.29B | -1.12% | 2,181,026 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.89B | -0.60% | 48,573 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.73B | -0.03% | 119,372 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.71B | 1.97% | 20,934 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.53B | -1.23% | 22,735 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.17B | -0.90% | 26,779 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.41% | 661,698 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | -0.09% | 927,702 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.88B | -2.29% | 38,236 | 189.76M |
| 41 | CGON | CG Oncology, Inc. | 5.69B | 0.88% | 36,319 | 4.04M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.64B | -0.97% | 44,162 | 1.73B |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.62B | -0.93% | 180,548 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.58B | -2.19% | 32,817 | 521.31M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.57B | -1.87% | 218,915 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 5.40B | -0.25% | 58,266 | 7.50M |
| 47 | CELC | Celcuity Inc. | 5.39B | -1.17% | 30,425 | - |
| 48 | CAI | Caris Life Sciences, Inc. | 5.30B | -1.96% | 81,108 | 812.03M |
| 49 | ERAS | Erasca, Inc. | 5.28B | 2.41% | 322,476 | - |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.16B | -0.02% | 1,479,578 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 4.96B | -2.91% | 412,564 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.91B | -0.98% | 111,677 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.58B | -2.27% | 111,822 | 3.51M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.53B | -0.03% | 313,222 | 634.21M |
| 55 | CORT | Corcept Therapeutics Incorporated | 4.52B | 1.24% | 95,996 | 761.41M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.48B | 0.18% | 43,193 | 2.04M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.92B | -1.45% | 11,540 | 268.09M |
| 58 | VKTX | Viking Therapeutics, Inc. | 3.87B | 1.70% | 370,690 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.78B | -1.31% | 69,118 | 7.70M |
| 60 | SYRE | Spyre Therapeutics, Inc. | 3.75B | -2.31% | 36,601 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -1.66% | 110,182 | 1.07B |
| 62 | GPCR | Structure Therapeutics Inc. | 3.73B | 4.86% | 102,848 | - |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.70B | -1.86% | 40,114 | 22.50M |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -1.03% | 90,339 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.49B | -1.05% | 157,648 | 1.03B |
| 66 | DNLI | Denali Therapeutics Inc. | 3.14B | 0.51% | 72,201 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.04B | -2.16% | 33,103 | 803.79M |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.02B | -0.42% | 381,169 | 62.38M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.99B | -1.25% | 29,177 | 588.99M |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | 0.09% | 11,832 | 451.36M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.98B | -0.28% | 66,237 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 2.91B | 6.46% | 369,330 | 247.00M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.91B | -2.57% | 64,646 | 376.07M |
| 74 | ALMS | Alumis Inc. | 2.89B | 0.04% | 71,239 | 24.05M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.88B | -0.37% | 44,325 | - |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.83B | -0.80% | 58,118 | 218.71M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.81B | -3.06% | 60,507 | 490.73M |
| 78 | ORKA | Oruka Therapeutics, Inc. | 2.52B | 0.95% | 90,001 | - |
| 79 | IMNM | Immunome, Inc. | 2.50B | -1.51% | 74,514 | 6.94M |
| 80 | KOD | Kodiak Sciences Inc. | 2.46B | -6.80% | 211,309 | - |
| 81 | AAPG | Ascentage Pharma Group International | 2.44B | -0.14% | 184 | 82.08M |
| 82 | IRON | Disc Medicine, Inc. | 2.44B | -1.49% | 11,225 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 2.40B | -0.39% | 136,645 | 139.74M |
| 84 | SRPT | Sarepta Therapeutics, Inc. | 2.32B | -0.05% | 263,177 | 2.20B |
| 85 | ZLAB | Zai Lab Limited | 2.25B | -1.70% | 113,472 | 460.16M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.24B | -0.77% | 34,511 | - |
| 87 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.05% | 233,222 | 158.18M |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | -2.01% | 95,187 | 276.98M |
| 89 | MANE | Veradermics, Incorporated | 2.18B | -0.82% | 40,898 | - |
| 90 | NKTR | Nektar Therapeutics | 2.17B | -0.26% | 77,243 | 55.23M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.14B | -1.76% | 30,958 | - |
| 92 | ADMA | ADMA Biologics, Inc. | 2.14B | -1.54% | 730,483 | 510.17M |
| 93 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | -0.04% | 145,253 | 172.35M |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.10B | -0.14% | 118,693 | 673.00M |
| 95 | TYRA | Tyra Biosciences, Inc. | 2.09B | 1.15% | 105,355 | - |
| 96 | RLAY | Relay Therapeutics, Inc. | 2.05B | 6.31% | 642,744 | 15.36M |
| 97 | DFTX | Definium Therapeutics, Inc. | 2.04B | -0.87% | 138,949 | - |
| 98 | CLDX | Celldex Therapeutics, Inc. | 2.03B | -2.46% | 640,168 | 1.55M |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 0.61% | 79,861 | 54.03M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -2.39% | 57,365 | 283.06M |
| 101 | GLPG | Galapagos NV | 1.98B | -1.51% | 21,369 | 1.31B |
| 102 | SLNO | Soleno Therapeutics, Inc. | 1.98B | 3.57% | 252,004 | 190.41M |
| 103 | ZYME | Zymeworks Inc. | 1.94B | 1.50% | 74,059 | 105.97M |
| 104 | VRDN | Viridian Therapeutics, Inc. | 1.93B | -1.57% | 217,035 | 70.85M |
| 105 | MESO | Mesoblast Limited | 1.91B | -5.38% | 19,449 | 65.38M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.86B | -0.10% | 56,301 | - |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.84B | -2.81% | 43,997 | 184.42M |
| 108 | PHVS | Pharvaris N.V. | 1.81B | -5.30% | 7,384 | - |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.81B | -0.36% | 185,243 | 51.95M |
| 110 | CAPR | Capricor Therapeutics, Inc. | 1.72B | -0.53% | 77,304 | 11.13M |
| 111 | INVA | Innoviva, Inc. | 1.71B | -1.28% | 27,808 | 411.33M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.69B | -2.08% | 44,062 | - |
| 113 | GENB | Generate Biomedicines, Inc. | 1.68B | -1.01% | 25,725 | 31.89M |
| 114 | ANAB | AnaptysBio, Inc. | 1.66B | 1.90% | 33,072 | 234.60M |
| 115 | NBTX | Nanobiotix S.A. | 1.63B | -9.39% | 16,856 | 11.93M |
| 116 | VCEL | Vericel Corporation | 1.60B | -3.53% | 19,733 | 276.26M |
| 117 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | -1.96% | 1,252,478 | 74.68M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -1.03% | 104,290 | 83.98M |
| 119 | HRMY | Harmony Biosciences Holdings, Inc. | 1.58B | -2.47% | 58,309 | 868.45M |
| 120 | OCS | Oculis Holding AG | 1.57B | -1.78% | 6,647 | 1.51M |
| 121 | MBX | MBX Biosciences, Inc. | 1.57B | 2.23% | 46,125 | - |
| 122 | NUVB | Nuvation Bio Inc. | 1.54B | -0.33% | 210,349 | 62.90M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.52B | 0.71% | 14,599 | - |
| 124 | IMCR | Immunocore Holdings plc | 1.52B | -0.79% | 7,159 | 400.02M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.51B | 1.81% | 52,229 | - |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.51B | -3.99% | 576,208 | 67.67M |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.50B | -0.92% | 26,660 | - |
| 128 | BHVN | Biohaven Ltd. | 1.49B | 2.81% | 277,621 | - |
| 129 | VIR | Vir Biotechnology, Inc. | 1.46B | 1.22% | 261,144 | 68.56M |
| 130 | ARDX | Ardelyx, Inc. | 1.45B | -3.03% | 231,013 | 407.32M |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.44B | -0.17% | 42,798 | 2.50M |
| 132 | SVRA | Savara Inc. | 1.41B | -0.36% | 70,496 | - |
| 133 | IOVA | Iovance Biotherapeutics, Inc. | 1.40B | -1.16% | 793,366 | 263.50M |
| 134 | IMTX | Immatics N.V. | 1.39B | 3.55% | 97,993 | 56.67M |
| 135 | GLUE | Monte Rosa Therapeutics, Inc. | 1.38B | 0.17% | 114,089 | 123.67M |
| 136 | PGEN | Precigen, Inc. | 1.36B | -2.04% | 509,065 | 9.68M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.33B | -0.83% | 16,233 | - |
| 138 | ATAI | AtaiBeckley Inc. | 1.32B | -2.16% | 193,700 | 4.09M |
| 139 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -1.19% | 56,629 | - |
| 140 | WVE | Wave Life Sciences Ltd. | 1.28B | -0.07% | 419,189 | 42.73M |
| 141 | NVAX | Novavax, Inc. | 1.26B | -3.80% | 440,277 | 1.12B |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.23B | -1.04% | 138,322 | 9.77M |
| 143 | DBVT | DBV Technologies S.A. | 1.21B | -1.37% | 124,211 | 5.64M |
| 144 | ZBIO | Zenas BioPharma, Inc. | 1.20B | -1.11% | 60,735 | 10.00M |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | -1.25% | 56,329 | - |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.16B | -1.82% | 110,310 | - |
| 147 | PHAR | Pharming Group N.V. | 1.16B | -2.36% | 3,122 | 376.13M |
| 148 | EYPT | EyePoint, Inc. | 1.09B | 0.54% | 76,604 | 31.37M |
| 149 | SEPN | Septerna, Inc. | 1.08B | -0.94% | 7,307 | 45.95M |
| 150 | QURE | uniQure N.V. | 1.08B | 2.61% | 161,682 | 16.10M |
| 151 | AVBP | ArriVent BioPharma, Inc. | 1.08B | 1.11% | 34,043 | - |
| 152 | ABCL | AbCellera Biologics Inc. | 1.06B | -0.71% | 221,633 | 75.13M |
| 153 | GERN | Geron Corporation | 1.04B | -2.11% | 1,652,610 | 183.88M |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -0.50% | 179,804 | 291.85M |
| 155 | IVA | Inventiva S.A. | 1.01B | 0.37% | 43,110 | 9.31M |
| 156 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | -0.61% | 70,131 | 73.62M |
| 157 | CMPX | Compass Therapeutics, Inc. | 974.28M | -0.37% | 211,549 | 850.00K |
| 158 | CTMX | CytomX Therapeutics, Inc. | 955.50M | -3.07% | 226,701 | 76.20M |
| 159 | INBX | Inhibrx Biosciences, Inc. | 948.29M | -3.18% | 11,785 | 1.30M |
| 160 | AKTS | Aktis Oncology, Inc. | 934.72M | -0.94% | 32,448 | 6.50M |
| 161 | XNCR | Xencor, Inc. | 930.67M | 1.28% | 42,389 | 125.58M |
| 162 | URGN | UroGen Pharma Ltd. | 919.61M | -0.26% | 30,016 | 109.79M |
| 163 | MPLT | MapLight Therapeutics, Inc. | 903.59M | -1.46% | 7,556 | - |
| 164 | GHRS | GH Research PLC | 894.46M | -2.04% | 2,521 | - |
| 165 | JANX | Janux Therapeutics, Inc. | 891.18M | 0.96% | 101,895 | 10.00M |
| 166 | ABUS | Arbutus Biopharma Corporation | 872.81M | -1.22% | 60,338 | 14.08M |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 871.58M | 3.30% | 537,045 | - |
| 168 | PHAT | Phathom Pharmaceuticals, Inc. | 858.12M | -2.24% | 64,506 | 175.11M |
| 169 | ANNX | Annexon, Inc. | 856.93M | -0.37% | 241,700 | - |
| 170 | FTRE | Fortrea Holdings Inc. | 846.18M | -4.84% | 128,501 | 2.72B |
| 171 | ORIC | ORIC Pharmaceuticals, Inc. | 836.99M | 11.57% | 1,442,955 | - |
| 172 | OMER | Omeros Corporation | 813.56M | -6.46% | 344,010 | - |
| 173 | TBPH | Theravance Biopharma, Inc. | 812.30M | -0.41% | 20,347 | 107.46M |
| 174 | EVMN | Evommune, Inc. | 805.73M | -0.22% | 13,878 | 13.00M |
| 175 | SGP | SpyGlass Pharma, Inc. | 799.62M | -1.80% | 28,385 | - |
| 176 | JBIO | Jade Biosciences, Inc. | 798.18M | 1.03% | 16,888 | - |
| 177 | SANA | Sana Biotechnology, Inc. | 792.59M | -2.62% | 948,705 | - |
| 178 | TENX | Tenax Therapeutics, Inc. | 777.39M | -3.41% | 8,820 | - |
| 179 | SPRY | ARS Pharmaceuticals, Inc. | 770.55M | -4.32% | 230,265 | 84.28M |
| 180 | KURA | Kura Oncology, Inc. | 749.04M | 1.68% | 368,961 | 67.48M |
| 181 | MNKD | MannKind Corporation | 747.14M | -4.53% | 341,585 | 348.97M |
| 182 | SLS | SELLAS Life Sciences Group, Inc. | 741.68M | -1.90% | 748,726 | - |
| 183 | MGTX | MeiraGTx Holdings plc | 741.16M | 0.11% | 55,889 | 81.39M |
| 184 | SLDB | Solid Biosciences Inc. | 730.06M | 0.54% | 54,297 | - |
| 185 | MRVI | Maravai LifeSciences Holdings, Inc. | 727.50M | -1.39% | 74,430 | 185.74M |
| 186 | RLMD | Relmada Therapeutics, Inc. | 724.79M | -2.68% | 155,322 | - |
| 187 | VOR | Vor Biopharma Inc. | 724.52M | 0.34% | 133,360 | - |
| 188 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 718.69M | -0.55% | 15,110 | - |
| 189 | ARVN | Arvinas, Inc. | 705.49M | -2.65% | 597,390 | 262.60M |
| 190 | DRUG | Bright Minds Biosciences Inc. | 691.10M | -2.40% | 32,468 | - |
| 191 | ANRO | Alto Neuroscience, Inc. | 683.00M | -8.67% | 137,373 | - |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 682.13M | -1.83% | 226,051 | 49.80M |
| 193 | REPL | Replimune Group, Inc. | 677.10M | 7.75% | 264,679 | - |
| 194 | DSGN | Design Therapeutics, Inc. | 661.74M | -2.54% | 6,737 | - |
| 195 | CBIO | Crescent Biopharma, Inc. | 637.71M | -0.62% | 15,204 | 10.84M |
| 196 | GYRE | Gyre Therapeutics, Inc. | 636.46M | -3.60% | 11,416 | 116.59M |
| 197 | LBRX | LB Pharmaceuticals Inc | 632.48M | 0.77% | 38,970 | - |
| 198 | ALLO | Allogene Therapeutics, Inc. | 627.73M | 0.59% | 472,919 | 22.00K |
| 199 | DRTS | Alpha Tau Medical Ltd. | 595.83M | -2.17% | 9,816 | - |
| 200 | OCGN | Ocugen, Inc. | 584.56M | -3.35% | 660,300 | 4.41M |
| 201 | PRME | Prime Medicine, Inc. | 584.36M | -2.65% | 127,304 | 4.63M |
| 202 | MDXG | MiMedx Group, Inc. | 570.50M | -2.78% | 48,430 | 418.63M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 570.25M | -1.33% | 11,439 | - |
| 204 | VALN | Valneva SE | 569.36M | -2.71% | 93,559 | 205.07M |
| 205 | ZURA | Zura Bio Limited | 569.28M | -0.50% | 39,978 | - |
| 206 | ACRS | Aclaris Therapeutics, Inc. | 568.49M | -1.21% | 86,437 | 7.83M |
| 207 | AGMB | AgomAb Therapeutics NV | 562.42M | -2.04% | 10,484 | - |
| 208 | CRMD | CorMedix Inc. | 546.24M | -1.57% | 92,110 | 311.71M |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 544.26M | -1.49% | 70,590 | 106.47M |
| 210 | KYTX | Kyverna Therapeutics, Inc. | 533.82M | 0.68% | 60,394 | - |
| 211 | PRTA | Prothena Corporation plc | 531.33M | -1.60% | 17,930 | 9.68M |
| 212 | YDES | YD Bio Limited | 522.48M | 1.92% | 924 | 510.36K |
| 213 | PROK | ProKidney Corp. | 522.31M | -1.14% | 128,448 | 893.00K |
| 214 | EIKN | Eikon Therapeutics, Inc. | 518.25M | -4.76% | 11,671 | - |
| 215 | VTVT | vTv Therapeutics Inc. | 517.48M | 2.89% | 10,886 | 17.00K |
| 216 | FULC | Fulcrum Therapeutics, Inc. | 506.16M | 1.60% | 73,925 | 80.00M |
| 217 | UPB | Upstream Bio, Inc. | 504.20M | -0.48% | 51,672 | 2.85M |
| 218 | RIGL | Rigel Pharmaceuticals, Inc. | 496.00M | -2.36% | 13,214 | 294.28M |
| 219 | CTNM | Contineum Therapeutics, Inc. | 490.60M | -2.30% | 2,079 | - |
| 220 | VSTM | Verastem, Inc. | 489.24M | 0.36% | 141,220 | 30.91M |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 486.01M | -3.55% | 82,643 | 85.21M |
| 222 | ABSI | Absci Corporation | 483.55M | 0.32% | 301,230 | 2.80M |
| 223 | LRMR | Larimar Therapeutics, Inc. | 476.82M | -1.92% | 48,179 | - |
| 224 | TRDA | Entrada Therapeutics, Inc. | 472.32M | -2.67% | 10,948 | 25.42M |
| 225 | LYEL | Lyell Immunopharma, Inc. | 471.04M | -2.88% | 10,655 | 36.00K |
| 226 | ADCT | ADC Therapeutics SA | 467.52M | -3.16% | 77,069 | 81.36M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 456.57M | -3.14% | 34,530 | - |
| 228 | ASMB | Assembly Biosciences, Inc. | 450.50M | -3.50% | 1,394 | 72.30M |
| 229 | IMMX | Immix Biopharma, Inc. | 450.20M | -1.39% | 29,606 | - |
| 230 | AVIR | Atea Pharmaceuticals, Inc. | 449.35M | -0.18% | 17,252 | - |
| 231 | STTK | Shattuck Labs, Inc. | 446.20M | -0.24% | 19,246 | 1.00M |
| 232 | ENGN | enGene Holdings Inc. | 439.45M | -2.96% | 5,252 | - |
| 233 | RGNX | REGENXBIO Inc. | 438.71M | -1.51% | 45,181 | 170.44M |
| 234 | AURA | Aura Biosciences, Inc. | 431.73M | 0.45% | 6,956 | - |
| 235 | FBRX | Forte Biosciences, Inc. | 423.32M | -4.51% | 18,788 | - |
| 236 | ALT | Altimmune, Inc. | 414.38M | 2.08% | 526,642 | 41.00K |
| 237 | NAUT | Nautilus Biotechnology, Inc. | 411.97M | -2.98% | 49,386 | - |
| 238 | STRO | Sutro Biopharma, Inc. | 410.70M | -0.32% | 5,668 | 102.48M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 409.70M | -2.47% | 34,389 | - |
| 240 | VNDA | Vanda Pharmaceuticals Inc. | 400.75M | -4.10% | 87,568 | 216.11M |
| 241 | LCTX | Lineage Cell Therapeutics, Inc. | 389.82M | -1.57% | 94,048 | 14.56M |
| 242 | XFOR | X4 Pharmaceuticals, Inc. | 388.68M | -1.72% | 31,150 | 35.11M |
| 243 | ARMP | Armata Pharmaceuticals, Inc. | 386.84M | - | 1,285 | 4.90M |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 386.51M | -1.66% | 138,800 | - |
| 245 | DNA | Ginkgo Bioworks Holdings, Inc. | 386.50M | -2.21% | 290,697 | 170.16M |
| 246 | XOMA | XOMA Royalty Corporation | 386.25M | -2.01% | 16,482 | 52.15M |
| 247 | IPSC | Century Therapeutics, Inc. | 385.51M | -2.05% | 70,253 | 109.16M |
| 248 | AVTX | Avalo Therapeutics, Inc. | 380.57M | - | 18,288 | 59.00K |
| 249 | BNTC | Benitec Biopharma Inc. | 376.46M | 0.18% | 2,374 | - |
| 250 | NMRA | Neumora Therapeutics, Inc. | 373.18M | -1.91% | 256,224 | - |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 371.74M | -1.23% | 5,347 | 66.98M |
| 252 | MNPR | Monopar Therapeutics Inc. | 370.68M | 0.14% | 24,126 | - |
| 253 | IVVD | Invivyd, Inc. | 368.79M | -1.88% | 1,123,253 | 53.43M |
| 254 | AUTL | Autolus Therapeutics plc | 361.95M | -1.45% | 175,729 | 75.39M |
| 255 | CADL | Candel Therapeutics, Inc. | 358.91M | -1.61% | 59,106 | - |
| 256 | PRTC | PureTech Health plc | 356.13M | 2.80% | 7,410 | 6.39M |
| 257 | IMRX | Immuneering Corporation | 350.42M | 1.69% | 86,321 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 350.03M | 1.78% | 26,109 | 228.37M |
| 259 | NAGE | Niagen Bioscience, Inc. | 349.08M | -3.76% | 77,579 | 129.42M |
| 260 | BCYC | Bicycle Therapeutics plc | 338.08M | -1.02% | 7,571 | 72.59M |
| 261 | PLYX | Polaryx Therapeutics, Inc. | 334.72M | -6.97% | 22,332 | - |
| 262 | DMAC | DiaMedica Therapeutics Inc. | 334.07M | -3.43% | 13,402 | - |
| 263 | CLYM | Climb Bio, Inc. | 331.51M | -0.14% | 15,048 | - |
| 264 | IRD | Opus Genetics, Inc. | 329.42M | -1.28% | 26,325 | 14.20M |
| 265 | NGEN | NervGen Pharma Corp. | 327.76M | -5.62% | 97,210 | - |
| 266 | NGNE | Neurogene Inc. | 327.53M | -2.91% | 2,885 | 925.00K |
| 267 | RZLT | Rezolute, Inc. | 323.04M | -0.64% | 62,748 | - |
| 268 | GLSI | Greenwich LifeSciences, Inc. | 319.21M | 0.35% | 11,257 | - |
| 269 | SRZN | Surrozen, Inc. | 316.57M | -3.09% | 9,581 | 3.48M |
| 270 | PALI | Palisade Bio, Inc. | 302.74M | -2.93% | 384,878 | - |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 301.65M | -2.21% | 47,090 | 1.00 |
| 272 | CABA | Cabaletta Bio, Inc. | 299.46M | 0.37% | 122,323 | - |
| 273 | LENZ | LENZ Therapeutics, Inc. | 299.28M | 2.09% | 57,835 | 19.09M |
| 274 | ANL | Adlai Nortye Ltd. | 291.88M | 0.13% | 16,032 | -1.35M |
| 275 | FHTX | Foghorn Therapeutics Inc. | 290.27M | 0.92% | 11,160 | 30.91M |
| 276 | NBP | NovaBridge Biosciences | 288.23M | 1.63% | 51,980 | - |
| 277 | PRLD | Prelude Therapeutics Incorporated | 288.05M | 1.16% | 16,260 | 12.14M |
| 278 | AVXL | Anavex Life Sciences Corp. | 278.48M | -3.06% | 178,426 | - |
| 279 | OVID | Ovid Therapeutics Inc. | 275.62M | -3.24% | 108,101 | 7.25M |
| 280 | SABS | SAB Biotherapeutics, Inc. | 271.97M | - | 13,540 | 114.70K |
| 281 | ACIU | AC Immune SA | 271.81M | -1.79% | 6,264 | 4.51M |
| 282 | SLGL | Sol-Gel Technologies Ltd. | 271.00M | -0.72% | 2,996 | 19.39M |
| 283 | ALEC | Alector, Inc. | 269.28M | -3.56% | 62,322 | 21.05M |
| 284 | TARA | Protara Therapeutics, Inc. | 267.72M | -1.79% | 22,865 | - |
| 285 | ABEO | Abeona Therapeutics Inc. | 266.42M | 1.97% | 65,496 | 5.82M |
| 286 | CCCC | C4 Therapeutics, Inc. | 262.49M | -0.37% | 82,258 | 35.95M |
| 287 | ALXO | ALX Oncology Holdings Inc. | 259.27M | -0.51% | 17,596 | - |
| 288 | SLN | Silence Therapeutics plc | 256.72M | -0.64% | 21,246 | 559.00K |
| 289 | CHRS | Coherus Oncology, Inc. | 254.81M | -2.30% | 162,625 | 42.17M |
| 290 | CLLS | Cellectis S.A. | 253.71M | 0.30% | 667 | 79.59M |
| 291 | CNTX | Context Therapeutics Inc. | 253.59M | 4.15% | 186,371 | - |
| 292 | EDIT | Editas Medicine, Inc. | 252.02M | -1.34% | 144,725 | 40.52M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 245.79M | -3.23% | 41,120 | 33.48M |
| 294 | HELP | Cybin Inc. | 245.68M | -1.60% | 114,845 | - |
| 295 | CAMP | Camp4 Therapeutics Corporation | 237.53M | 2.58% | 4,395 | 3.50M |
| 296 | NERV | Minerva Neurosciences, Inc. | 237.36M | -2.05% | 6,495 | - |
| 297 | VYGR | Voyager Therapeutics, Inc. | 228.86M | -3.76% | 90,946 | 40.37M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 227.52M | -0.17% | 125,433 | - |
| 299 | KROS | Keros Therapeutics, Inc. | 226.75M | -1.63% | 29,394 | 244.06M |
| 300 | ENLV | Enlivex Ltd. | 225.49M | -1.29% | 16,979 | - |
| 301 | OABI | OmniAb, Inc. | 223.69M | -0.96% | 17,566 | 18.67M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 222.84M | -0.13% | 50,427 | 82.03M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 219.61M | -0.62% | 8,872 | 44.64M |
| 304 | CGEN | Compugen Ltd. | 212.75M | 2.27% | 75,792 | 72.76M |
| 305 | ADAG | Adagene Inc. | 207.38M | -4.56% | 445,768 | 103.20K |
| 306 | MDWD | MediWound Ltd. | 202.13M | -2.87% | 11,447 | 16.96M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 198.69M | -1.32% | 5,499 | - |
| 308 | ELTX | Elicio Therapeutics, Inc. | 193.53M | -1.31% | 27,003 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 188.93M | -2.78% | 41,027 | 13.11M |
| 310 | ABOS | Acumen Pharmaceuticals, Inc. | 187.03M | 1.57% | 77,472 | - |
| 311 | MGNX | MacroGenics, Inc. | 185.58M | 0.69% | 19,790 | 149.50M |
| 312 | KRRO | Korro Bio, Inc. | 184.18M | 0.95% | 24,277 | 6.39M |
| 313 | CRBU | Caribou Biosciences, Inc. | 183.61M | -4.52% | 169,660 | 11.16M |
| 314 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 182.51M | 3.11% | 23,883 | - |
| 315 | UNCY | Unicycive Therapeutics, Inc. | 176.41M | -1.83% | 85,720 | - |
| 316 | PRQR | ProQR Therapeutics N.V. | 175.95M | -2.34% | 58,016 | 19.19M |
| 317 | GALT | Galectin Therapeutics Inc. | 175.10M | -0.75% | 3,949 | - |
| 318 | PLX | Protalix BioTherapeutics, Inc. | 172.83M | -2.05% | 62,673 | 52.74M |
| 319 | ACHV | Achieve Life Sciences, Inc. | 171.97M | 2.87% | 146,284 | - |
| 320 | SGMT | Sagimet Biosciences Inc. | 169.44M | -0.76% | 13,223 | - |
| 321 | ZNTL | Zentalis Pharmaceuticals, Inc. | 169.00M | 1.56% | 23,153 | 26.87M |
| 322 | MENS | Jyong Biotech Ltd. | 168.80M | -3.73% | 7,780 | - |
| 323 | WHWK | Whitehawk Therapeutics, Inc. | 167.31M | 0.14% | 3,532 | 7.15M |
| 324 | RNAC | Cartesian Therapeutics, Inc. | 164.36M | -2.97% | 2,614 | 2.80M |
| 325 | ARTV | Artiva Biotherapeutics, Inc. | 161.89M | -2.96% | 14,320 | 251.00K |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 161.77M | -3.09% | 65,242 | - |
| 327 | TLSA | Tiziana Life Sciences Ltd | 156.99M | -1.59% | 1,960 | - |
| 328 | CDXS | Codexis, Inc. | 156.75M | -0.86% | 58,365 | 70.39M |
| 329 | CNTB | Connect Biopharma Holdings Limited | 156.53M | 2.94% | 216,532 | 64.00K |
| 330 | MIST | Milestone Pharmaceuticals Inc. | 155.76M | -3.05% | 322,955 | 1.55M |
| 331 | NKTX | Nkarta, Inc. | 153.27M | -1.83% | 42,189 | - |
| 332 | CBUS | Cibus, Inc. | 147.39M | 0.26% | 49,933 | 3.64M |
| 333 | HRTX | Heron Therapeutics, Inc. | 147.36M | -2.73% | 79,469 | 154.90M |
| 334 | DTIL | Precision BioSciences, Inc. | 146.30M | -0.35% | 31,900 | 34.26M |
| 335 | IMUX | Immunic, Inc. | 144.82M | -3.48% | 115,399 | - |
| 336 | MOLN | Molecular Partners AG | 143.73M | -2.67% | 151 | 856.30K |
| 337 | TNYA | Tenaya Therapeutics, Inc. | 143.22M | -3.08% | 443,286 | - |
| 338 | FATE | Fate Therapeutics, Inc. | 140.68M | -2.42% | 92,154 | 6.65M |
| 339 | SPRO | Spero Therapeutics, Inc. | 139.81M | -1.43% | 10,228 | 66.80M |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 137.21M | 2.79% | 107,323 | 70.00M |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 132.54M | -1.77% | 7,189 | 2.00M |
| 342 | ACOG | Alpha Cognition Inc. | 130.45M | 0.67% | 3,276 | 10.22M |
| 343 | HUMA | Humacyte, Inc. | 129.44M | -1.50% | 675,121 | 2.04M |
| 344 | KPTI | Karyopharm Therapeutics Inc. | 128.50M | -2.06% | 23,481 | 146.07M |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 126.79M | -6.82% | 1,608 | - |
| 346 | AGEN | Agenus Inc. | 125.95M | -3.53% | 32,031 | 114.20M |
| 347 | EQ | Equillium, Inc. | 124.37M | -3.58% | 8,561 | 4.39M |
| 348 | ANTX | AN2 Therapeutics, Inc. | 124.36M | 0.29% | 10,643 | - |
| 349 | IPHA | Innate Pharma S.A. | 122.33M | -0.74% | 2,083 | 10.57M |
| 350 | PMN | ProMIS Neurosciences, Inc. | 120.53M | 3.38% | 1,764 | - |
| 351 | NTHI | NeOnc Technologies Holdings, Inc. | 119.50M | -1.97% | 1,063 | 39.99K |
| 352 | PEPG | PepGen Inc. | 117.15M | -2.59% | 307,806 | - |
| 353 | GNLX | Genelux Corporation | 110.04M | -3.13% | 24,121 | 8.00K |
| 354 | CRDF | Cardiff Oncology, Inc. | 105.97M | -3.73% | 91,434 | 593.00K |
| 355 | SGMO | Sangamo Therapeutics, Inc. | 102.37M | -5.00% | 876,317 | 39.55M |
| 356 | ONCY | Oncolytics Biotech Inc. | 102.23M | 2.14% | 125,226 | - |
| 357 | BMEA | Biomea Fusion, Inc. | 101.94M | -5.37% | 181,406 | - |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 99.30M | -1.79% | 390,955 | - |
| 359 | SEER | Seer, Inc. | 96.20M | 0.29% | 23,919 | 16.58M |
| 360 | SPRB | Spruce Biosciences, Inc. | 95.40M | - | 697 | 697.00K |
| 361 | LONA | LeonaBio, Inc. | 93.64M | 0.10% | 5,473 | - |
| 362 | HURA | TuHURA Biosciences, Inc. | 92.82M | -9.88% | 326,334 | - |
| 363 | VRCA | Verrica Pharmaceuticals Inc. | 92.77M | -1.64% | 2,932 | 35.58M |
| 364 | TTRX | Turn Therapeutics Inc. | 92.75M | 1.12% | 8,079 | - |
| 365 | COYA | Coya Therapeutics, Inc. | 92.66M | -3.19% | 8,869 | 7.95M |
| 366 | PYXS | Pyxis Oncology, Inc. | 92.36M | - | 53,055 | 13.86M |
| 367 | ANIX | Anixa Biosciences, Inc. | 87.17M | -4.41% | 17,168 | - |
| 368 | AARD | Aardvark Therapeutics, Inc. | 85.52M | -4.16% | 11,064 | - |
| 369 | OKYO | OKYO Pharma Limited | 85.02M | -2.41% | 1,389 | - |
| 370 | QTTB | Q32 Bio Inc. | 84.85M | -5.07% | 16,332 | 53.74M |
| 371 | MCRB | Seres Therapeutics, Inc. | 84.55M | -0.45% | 1,362 | 789.00K |
| 372 | VANI | Vivani Medical, Inc. | 83.35M | -1.53% | 25,295 | - |
| 373 | PYPD | PolyPid Ltd. | 83.20M | -0.68% | 2,534 | - |
| 374 | PLRX | Pliant Therapeutics, Inc. | 82.66M | 1.14% | 30,803 | - |
| 375 | FLNA | Filana Therapeutics, Inc. | 82.61M | -0.58% | 77,035 | - |
| 376 | GOSS | Gossamer Bio, Inc. | 82.14M | -4.11% | 1,107,541 | 48.47M |
| 377 | CSBR | Champions Oncology, Inc. | 82.14M | 2.01% | 85 | 57.95M |
| 378 | GANX | Gain Therapeutics, Inc. | 80.47M | -1.80% | 32,337 | - |
| 379 | KZIA | Kazia Therapeutics Limited | 80.45M | -1.95% | 2,385 | 1.27M |
| 380 | ATYR | aTyr Pharma, Inc. | 80.27M | -3.77% | 193,642 | 190.00K |
| 381 | MAIA | MAIA Biotechnology, Inc. | 80.09M | -1.49% | 50,438 | - |
| 382 | INO | Inovio Pharmaceuticals, Inc. | 79.46M | -33.91% | 4,510,005 | 65.34K |
| 383 | FBIO | Fortress Biotech, Inc. | 77.59M | 1.21% | 64,789 | 62.30M |
| 384 | NRXS | NeurAxis, Inc. | 77.24M | -3.85% | 12,285 | 3.57M |
| 385 | RANI | Rani Therapeutics Holdings, Inc. | 77.15M | -3.94% | 155,693 | 1.63M |
| 386 | CGTX | Cognition Therapeutics, Inc. | 75.06M | -5.77% | 329,382 | - |
| 387 | GRCE | Grace Therapeutics, Inc. | 73.81M | -2.25% | 93,589 | - |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 73.31M | 4.43% | 1,968 | 1.36M |
| 389 | ACET | Adicet Bio, Inc. | 72.88M | -1.45% | 10,316 | - |
| 390 | XBIT | XBiotech Inc. | 71.55M | 0.30% | 1,809 | - |
| 391 | DWTX | Dogwood Therapeutics, Inc. | 71.31M | 0.23% | 997 | - |
| 392 | NRXP | NRx Pharmaceuticals, Inc. | 70.36M | -1.39% | 30,156 | 1.23M |
| 393 | BYSI | BeyondSpring Inc. | 70.31M | 0.29% | 25 | 1.88M |
| 394 | PTHS | Pelthos Therapeutics Inc. | 70.13M | -1.88% | 1,913 | 16.80M |
| 395 | GUTS | Fractyl Health, Inc. | 70.12M | -4.88% | 109,793 | 3.00K |
| 396 | CING | Cingulate Inc. | 70.00M | 0.17% | 97,071 | - |
| 397 | MNOV | MediciNova, Inc. | 69.89M | - | 3,184 | 409.66K |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 69.86M | -1.50% | 15,103 | - |
| 399 | EXOZ | eXoZymes, Inc. | 68.38M | -3.55% | 245 | -700.00 |
| 400 | ATHE | Alterity Therapeutics Limited | 67.90M | -3.47% | 627 | 4.43M |
| 401 | IBIO | iBio, Inc. | 67.01M | -0.51% | 29,526 | 300.00K |
| 402 | IBO | Impact BioMedical Inc. | 63.65M | -3.83% | 22,956 | 32.00K |
| 403 | ENTX | Entera Bio Ltd. | 62.94M | 18.42% | 422,474 | 42.00K |
| 404 | IFRX | InflaRx N.V. | 62.89M | -3.65% | 26,492 | 34.44K |
| 405 | ANVS | Annovis Bio, Inc. | 58.41M | -2.83% | 15,918 | - |
| 406 | TCRX | TScan Therapeutics, Inc. | 58.04M | -0.97% | 136,952 | 10.33M |
| 407 | ICCC | ImmuCell Corporation | 57.53M | 0.16% | 284 | 27.64M |
| 408 | ACTU | Actuate Therapeutics, Inc. | 56.90M | -3.61% | 3,500 | - |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 56.13M | -0.77% | 73,200 | - |
| 410 | IMA | ImageneBio, Inc. | 56.04M | -0.79% | 3,214 | 800.00K |
| 411 | HYFT | MindWalk Holdings Corp. | 55.63M | -1.75% | 25,445 | 20.70M |
| 412 | OKUR | OnKure Therapeutics, Inc. | 55.51M | -0.25% | 6,847 | - |
| 413 | KZR | Kezar Life Sciences, Inc. | 54.18M | -0.68% | 4,566 | - |
| 414 | MREO | Mereo BioPharma Group plc | 53.14M | 0.88% | 243,351 | 500.00K |
| 415 | TIL | Instil Bio, Inc. | 52.76M | -3.11% | 1,286 | - |
| 416 | OSTX | OS Therapies Incorporated | 52.58M | -2.21% | 45,156 | - |
| 417 | RADX | Radiopharm Theranostics Limited | 51.63M | -2.31% | 614 | 10.86M |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 49.28M | -2.24% | 20,886 | 25.21M |
| 419 | INKT | MiNK Therapeutics, Inc. | 49.15M | -0.95% | 3,784 | - |
| 420 | HOWL | Werewolf Therapeutics, Inc. | 48.60M | 4.34% | 174,357 | 1.14M |
| 421 | XLO | Xilio Therapeutics, Inc. | 48.38M | -1.35% | 7,043 | 43.77M |
| 422 | EDSA | Edesa Biotech, Inc. | 47.75M | 3.06% | 86,958 | - |
| 423 | ALGS | Aligos Therapeutics, Inc. | 46.35M | -3.23% | 2,666 | 2.19M |
| 424 | LSTA | Lisata Therapeutics, Inc. | 45.30M | 0.10% | 2,608 | 170.00K |
| 425 | TELO | Telomir Pharmaceuticals, Inc. | 45.04M | -0.76% | 7,310 | - |
| 426 | IMMP | Immutep Limited | 44.98M | -3.03% | 57,465 | 5.28M |
| 427 | ESLA | Estrella Immunopharma, Inc. | 44.80M | -0.48% | 44 | - |
| 428 | NTRB | Nutriband Inc. | 44.35M | 1.34% | 746 | 2.28M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 43.87M | -0.29% | 3,993 | - |
| 430 | RNXT | RenovoRx, Inc. | 43.70M | - | 6,045 | 1.12M |
| 431 | RLYB | Rallybio Corporation | 43.38M | -2.38% | 932 | 858.00K |
| 432 | ATRA | Atara Biotherapeutics, Inc. | 42.69M | 0.97% | 6,339 | 120.77M |
| 433 | NBY | NovaBay Pharmaceuticals, Inc. | 41.84M | -1.16% | 19,361 | 10.30M |
| 434 | SNSE | Sensei Biotherapeutics, Inc. | 40.49M | -8.02% | 4,680 | - |
| 435 | LITS | Lite Strategy, Inc. | 40.00M | -2.65% | 50,804 | - |
| 436 | CELU | Celularity Inc. | 37.78M | - | 465 | 40.58M |
| 437 | CRVO | CervoMed Inc. | 37.31M | 0.75% | 3,761 | 4.01M |
| 438 | NXTC | NextCure, Inc. | 36.71M | -2.09% | 1,188 | - |
| 439 | VERU | Veru Inc. | 36.19M | -0.66% | 2,555 | 16.89M |
| 440 | PLUR | Pluri Inc. | 33.67M | - | 931 | 1.34M |
| 441 | PTN | Palatin Technologies, Inc. | 33.64M | 5.81% | 131 | 8.96M |
| 442 | LGVN | Longeveron Inc. | 33.38M | 1.79% | 353,627 | 1.20M |
| 443 | RNTX | Rein Therapeutics Inc. | 32.39M | -4.55% | 46,581 | - |
| 444 | PDSB | PDS Biotechnology Corporation | 32.10M | -3.25% | 18,108 | - |
| 445 | INMB | INmune Bio Inc. | 31.90M | -2.44% | 63,002 | 50.00K |
| 446 | APLM | Apollomics, Inc. | 31.48M | 1.38% | 154 | 6.93M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 30.86M | - | 8,808 | 90.00K |
| 448 | EVAX | Evaxion A/S | 30.11M | -8.38% | 889 | 7.53M |
| 449 | BCTX | BriaCell Therapeutics Corp. | 29.91M | -3.99% | 11,324 | - |
| 450 | DYAI | Dyadic International, Inc. | 29.57M | -4.76% | 4,113 | 3.09M |
| 451 | KYNB | Kyntra Bio, Inc. | 29.34M | 2.11% | 4,078 | 6.44M |
| 452 | HYPD | Hyperion DeFi, Inc. | 27.84M | -5.20% | 88,580 | 813.46K |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 27.49M | -2.33% | 10,935 | - |
| 454 | CVM | CEL-SCI Corporation | 27.19M | -2.04% | 3,837 | - |
| 455 | ABVC | ABVC BioPharma, Inc. | 27.18M | 1.85% | 23,040 | 797.92K |
| 456 | DARE | Daré Bioscience, Inc. | 26.86M | -2.89% | 14,827 | 1.03M |
| 457 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.57M | -0.49% | 369 | - |
| 458 | SNTI | Senti Biosciences, Inc. | 26.11M | -0.05% | 26,317 | 22.00K |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 26.05M | 2.62% | 9,809 | - |
| 460 | XCUR | Exicure, Inc. | 25.75M | -3.35% | 796 | 500.00K |
| 461 | QNTM | Quantum BioPharma Ltd. | 25.36M | -8.16% | 215,593 | - |
| 462 | IGC | IGC Pharma, Inc. | 25.08M | -3.56% | 23,844 | 1.11M |
| 463 | AEON | AEON Biopharma, Inc. | 24.80M | 0.16% | 5,789 | - |
| 464 | PASG | Passage Bio, Inc. | 24.48M | -2.80% | 3,580 | - |
| 465 | BOLD | Boundless Bio, Inc. | 24.42M | -3.54% | 148,613 | - |
| 466 | SER | Serina Therapeutics, Inc. | 24.39M | -6.59% | 61,891 | 130.00K |
| 467 | PSTV | Plus Therapeutics, Inc. | 24.36M | -8.86% | 214,697 | 5.21M |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 23.54M | -1.08% | 20,737 | 789.00K |
| 469 | TPST | Tempest Therapeutics, Inc. | 22.95M | -1.23% | 16,857 | - |
| 470 | COCP | Cocrystal Pharma, Inc. | 22.74M | 61.76% | 98,030,844 | - |
| 471 | LEXX | Lexaria Bioscience Corp. | 22.15M | 2.75% | 59,836 | 522.00K |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 22.13M | -0.36% | 6,800 | 14.99M |
| 473 | BRNS | Barinthus Biotherapeutics plc | 22.06M | -0.02% | 2,150 | 14.97M |
| 474 | MRKR | Marker Therapeutics, Inc. | 21.51M | -1.53% | 4,535 | 3.55M |
| 475 | CRIS | Curis, Inc. | 21.34M | 0.14% | 80,298 | 9.44M |
| 476 | OTLK | Outlook Therapeutics, Inc. | 21.07M | -4.10% | 172,162 | 205.70K |
| 477 | SKYE | Skye Bioscience, Inc. | 21.04M | -5.19% | 32,877 | - |
| 478 | JSPR | Jasper Therapeutics, Inc. | 20.93M | -6.51% | 152,241 | - |
| 479 | PLRZ | Polyrizon Ltd. | 20.89M | 2.14% | 3,572 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.17M | -0.13% | 3,344 | 570.00K |
| 481 | CYCN | Cyclerion Therapeutics, Inc. | 20.06M | -17.40% | 5,186,890 | 2.07M |
| 482 | NNVC | NanoViricides, Inc. | 19.65M | -4.67% | 117,131 | - |
| 483 | CUE | Cue Biopharma, Inc. | 18.48M | -6.61% | 196,953 | 27.47M |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 18.48M | -2.06% | 45,783 | 3.94M |
| 485 | ALLR | Allarity Therapeutics, Inc. | 18.01M | -0.88% | 4,374 | 320.00K |
| 486 | TVGN | Tevogen Bio Holdings Inc. | 17.61M | -5.58% | 5,146 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.16M | -0.09% | 121,432 | - |
| 488 | GNTA | Genenta Science S.p.A. | 16.29M | -0.26% | 6,709 | - |
| 489 | LTRN | Lantern Pharma Inc. | 15.36M | -3.52% | 110,346 | - |
| 490 | PHIO | Phio Pharmaceuticals Corp. | 14.75M | -2.31% | 22,190 | - |
| 491 | LPCN | Lipocine Inc. | 14.53M | -78.49% | 3,562,643 | 1.98M |
| 492 | INTS | Intensity Therapeutics, Inc. | 14.49M | 0.27% | 12,243 | - |
| 493 | ICU | SeaStar Medical Holding Corporation | 13.94M | -1.97% | 17,238 | 1.23M |
| 494 | OSRH | OSR Holdings, Inc. | 13.68M | -9.14% | 208,909 | 2.91M |
| 495 | INAB | IN8bio, Inc. | 13.49M | -2.14% | 1,655 | - |
| 496 | GTBP | GT Biopharma, Inc. | 13.25M | 2.59% | 81,086 | - |
| 497 | TRAW | Traws Pharma, Inc. | 13.18M | -0.60% | 2,690 | 2.85M |
| 498 | JUNS | Jupiter Neurosciences, Inc. | 12.57M | -3.87% | 10,645 | - |
| 499 | BCDA | BioCardia, Inc. | 12.47M | -1.72% | 5,905 | 3.00K |
| 500 | KAPA | Kairos Pharma, Ltd. | 11.93M | -0.97% | 7,017 | - |